According to our latest study, the global Nucleic Acid Multiplex Assay market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The publisher report includes an overview of the development of the Nucleic Acid Multiplex Assay industry chain, the market status of Pharmaceutical & Biotechnology Companies (Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays), Hospitals & Research Institutes (Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nucleic Acid Multiplex Assay.
Regionally, the report analyzes the Nucleic Acid Multiplex Assay markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nucleic Acid Multiplex Assay market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nucleic Acid Multiplex Assay market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nucleic Acid Multiplex Assay industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nucleic Acid Multiplex Assay market.
Regional Analysis: The report involves examining the Nucleic Acid Multiplex Assay market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nucleic Acid Multiplex Assay market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nucleic Acid Multiplex Assay:
Company Analysis: Report covers individual Nucleic Acid Multiplex Assay players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nucleic Acid Multiplex Assay This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes).
Technology Analysis: Report covers specific technologies relevant to Nucleic Acid Multiplex Assay. It assesses the current state, advancements, and potential future developments in Nucleic Acid Multiplex Assay areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nucleic Acid Multiplex Assay market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nucleic Acid Multiplex Assay market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Market segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other
Market segment by players, this report covers
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nucleic Acid Multiplex Assay product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nucleic Acid Multiplex Assay, with revenue, gross margin and global market share of Nucleic Acid Multiplex Assay from 2019 to 2024.
Chapter 3, the Nucleic Acid Multiplex Assay competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nucleic Acid Multiplex Assay market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nucleic Acid Multiplex Assay.
Chapter 13, to describe Nucleic Acid Multiplex Assay research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Nucleic Acid Multiplex Assay
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nucleic Acid Multiplex Assay by Type
1.3.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Type in 2023
1.3.3 Planar Nucleic Acid Assays
1.3.4 Bead-Based Nucleic Acid Assays
1.3.5 Other Nucleic Acid Assays
1.4 Global Nucleic Acid Multiplex Assay Market by Application
1.4.1 Overview: Global Nucleic Acid Multiplex Assay Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Hospitals & Research Institutes
1.4.4 Reference Laboratories
1.4.5 Other
1.5 Global Nucleic Acid Multiplex Assay Market Size & Forecast
1.6 Global Nucleic Acid Multiplex Assay Market Size and Forecast by Region
1.6.1 Global Nucleic Acid Multiplex Assay Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nucleic Acid Multiplex Assay Market Size by Region, (2019-2030)
1.6.3 North America Nucleic Acid Multiplex Assay Market Size and Prospect (2019-2030)
1.6.4 Europe Nucleic Acid Multiplex Assay Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nucleic Acid Multiplex Assay Market Size and Prospect (2019-2030)
1.6.6 South America Nucleic Acid Multiplex Assay Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nucleic Acid Multiplex Assay Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Luminex Corporation (US)
2.1.1 Luminex Corporation (US) Details
2.1.2 Luminex Corporation (US) Major Business
2.1.3 Luminex Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.1.4 Luminex Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Luminex Corporation (US) Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc. (US)
2.2.1 Thermo Fisher Scientific Inc. (US) Details
2.2.2 Thermo Fisher Scientific Inc. (US) Major Business
2.2.3 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.2.4 Thermo Fisher Scientific Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Thermo Fisher Scientific Inc. (US) Recent Developments and Future Plans
2.3 Illumina, Inc (US)
2.3.1 Illumina, Inc (US) Details
2.3.2 Illumina, Inc (US) Major Business
2.3.3 Illumina, Inc (US) Nucleic Acid Multiplex Assay Product and Solutions
2.3.4 Illumina, Inc (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Illumina, Inc (US) Recent Developments and Future Plans
2.4 Bio-Rad Laboratories, Inc. (US)
2.4.1 Bio-Rad Laboratories, Inc. (US) Details
2.4.2 Bio-Rad Laboratories, Inc. (US) Major Business
2.4.3 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.4.4 Bio-Rad Laboratories, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bio-Rad Laboratories, Inc. (US) Recent Developments and Future Plans
2.5 Qiagen N.V. (Netherlands)
2.5.1 Qiagen N.V. (Netherlands) Details
2.5.2 Qiagen N.V. (Netherlands) Major Business
2.5.3 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Product and Solutions
2.5.4 Qiagen N.V. (Netherlands) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Qiagen N.V. (Netherlands) Recent Developments and Future Plans
2.6 Abcam plc (UK)
2.6.1 Abcam plc (UK) Details
2.6.2 Abcam plc (UK) Major Business
2.6.3 Abcam plc (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.6.4 Abcam plc (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Abcam plc (UK) Recent Developments and Future Plans
2.7 Becton, Dickinson and Company (US)
2.7.1 Becton, Dickinson and Company (US) Details
2.7.2 Becton, Dickinson and Company (US) Major Business
2.7.3 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.7.4 Becton, Dickinson and Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Becton, Dickinson and Company (US) Recent Developments and Future Plans
2.8 Merck KGaA (Germany)
2.8.1 Merck KGaA (Germany) Details
2.8.2 Merck KGaA (Germany) Major Business
2.8.3 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.8.4 Merck KGaA (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck KGaA (Germany) Recent Developments and Future Plans
2.9 Agilent Technologies, Inc. (US)
2.9.1 Agilent Technologies, Inc. (US) Details
2.9.2 Agilent Technologies, Inc. (US) Major Business
2.9.3 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.9.4 Agilent Technologies, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Agilent Technologies, Inc. (US) Recent Developments and Future Plans
2.10 Meso Scale Diagnostics (US)
2.10.1 Meso Scale Diagnostics (US) Details
2.10.2 Meso Scale Diagnostics (US) Major Business
2.10.3 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Product and Solutions
2.10.4 Meso Scale Diagnostics (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Meso Scale Diagnostics (US) Recent Developments and Future Plans
2.11 Randox Laboratories (UK)
2.11.1 Randox Laboratories (UK) Details
2.11.2 Randox Laboratories (UK) Major Business
2.11.3 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Product and Solutions
2.11.4 Randox Laboratories (UK) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Randox Laboratories (UK) Recent Developments and Future Plans
2.12 Quanterix (US)
2.12.1 Quanterix (US) Details
2.12.2 Quanterix (US) Major Business
2.12.3 Quanterix (US) Nucleic Acid Multiplex Assay Product and Solutions
2.12.4 Quanterix (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Quanterix (US) Recent Developments and Future Plans
2.13 Bio-Techne Corporation (US)
2.13.1 Bio-Techne Corporation (US) Details
2.13.2 Bio-Techne Corporation (US) Major Business
2.13.3 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.13.4 Bio-Techne Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Bio-Techne Corporation (US) Recent Developments and Future Plans
2.14 Olink (Sweden)
2.14.1 Olink (Sweden) Details
2.14.2 Olink (Sweden) Major Business
2.14.3 Olink (Sweden) Nucleic Acid Multiplex Assay Product and Solutions
2.14.4 Olink (Sweden) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Olink (Sweden) Recent Developments and Future Plans
2.15 DiaSorin S.p.A. (Italy)
2.15.1 DiaSorin S.p.A. (Italy) Details
2.15.2 DiaSorin S.p.A. (Italy) Major Business
2.15.3 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Product and Solutions
2.15.4 DiaSorin S.p.A. (Italy) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 DiaSorin S.p.A. (Italy) Recent Developments and Future Plans
2.16 Seegene (South Korea)
2.16.1 Seegene (South Korea) Details
2.16.2 Seegene (South Korea) Major Business
2.16.3 Seegene (South Korea) Nucleic Acid Multiplex Assay Product and Solutions
2.16.4 Seegene (South Korea) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Seegene (South Korea) Recent Developments and Future Plans
2.17 Promega Corporation (US)
2.17.1 Promega Corporation (US) Details
2.17.2 Promega Corporation (US) Major Business
2.17.3 Promega Corporation (US) Nucleic Acid Multiplex Assay Product and Solutions
2.17.4 Promega Corporation (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Promega Corporation (US) Recent Developments and Future Plans
2.18 Siemens Healthineers (Germany)
2.18.1 Siemens Healthineers (Germany) Details
2.18.2 Siemens Healthineers (Germany) Major Business
2.18.3 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.18.4 Siemens Healthineers (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Siemens Healthineers (Germany) Recent Developments and Future Plans
2.19 PerkinElmer, Inc. (US)
2.19.1 PerkinElmer, Inc. (US) Details
2.19.2 PerkinElmer, Inc. (US) Major Business
2.19.3 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.19.4 PerkinElmer, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 PerkinElmer, Inc. (US) Recent Developments and Future Plans
2.20 Shimadzu Biotech (Japan)
2.20.1 Shimadzu Biotech (Japan) Details
2.20.2 Shimadzu Biotech (Japan) Major Business
2.20.3 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Product and Solutions
2.20.4 Shimadzu Biotech (Japan) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Shimadzu Biotech (Japan) Recent Developments and Future Plans
2.21 Antigenix America, Inc. (US)
2.21.1 Antigenix America, Inc. (US) Details
2.21.2 Antigenix America, Inc. (US) Major Business
2.21.3 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.21.4 Antigenix America, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Antigenix America, Inc. (US) Recent Developments and Future Plans
2.22 Enzo Life Sciences, Inc. (US)
2.22.1 Enzo Life Sciences, Inc. (US) Details
2.22.2 Enzo Life Sciences, Inc. (US) Major Business
2.22.3 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Product and Solutions
2.22.4 Enzo Life Sciences, Inc. (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Enzo Life Sciences, Inc. (US) Recent Developments and Future Plans
2.23 Boster Biological Technology (US)
2.23.1 Boster Biological Technology (US) Details
2.23.2 Boster Biological Technology (US) Major Business
2.23.3 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Product and Solutions
2.23.4 Boster Biological Technology (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Boster Biological Technology (US) Recent Developments and Future Plans
2.24 AYOXXA Biosystems GmbH (Germany)
2.24.1 AYOXXA Biosystems GmbH (Germany) Details
2.24.2 AYOXXA Biosystems GmbH (Germany) Major Business
2.24.3 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Product and Solutions
2.24.4 AYOXXA Biosystems GmbH (Germany) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 AYOXXA Biosystems GmbH (Germany) Recent Developments and Future Plans
2.25 Cayman Chemical Company (US)
2.25.1 Cayman Chemical Company (US) Details
2.25.2 Cayman Chemical Company (US) Major Business
2.25.3 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Product and Solutions
2.25.4 Cayman Chemical Company (US) Nucleic Acid Multiplex Assay Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Cayman Chemical Company (US) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Nucleic Acid Multiplex Assay Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Nucleic Acid Multiplex Assay by Company Revenue
3.2.2 Top 3 Nucleic Acid Multiplex Assay Players Market Share in 2023
3.2.3 Top 6 Nucleic Acid Multiplex Assay Players Market Share in 2023
3.3 Nucleic Acid Multiplex Assay Market: Overall Company Footprint Analysis
3.3.1 Nucleic Acid Multiplex Assay Market: Region Footprint
3.3.2 Nucleic Acid Multiplex Assay Market: Company Product Type Footprint
3.3.3 Nucleic Acid Multiplex Assay Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Nucleic Acid Multiplex Assay Consumption Value and Market Share by Type (2019-2024)
4.2 Global Nucleic Acid Multiplex Assay Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Nucleic Acid Multiplex Assay Consumption Value Market Share by Application (2019-2024)
5.2 Global Nucleic Acid Multiplex Assay Market Forecast by Application (2025-2030)
6 North America
6.1 North America Nucleic Acid Multiplex Assay Consumption Value by Type (2019-2030)
6.2 North America Nucleic Acid Multiplex Assay Consumption Value by Application (2019-2030)
6.3 North America Nucleic Acid Multiplex Assay Market Size by Country
6.3.1 North America Nucleic Acid Multiplex Assay Consumption Value by Country (2019-2030)
6.3.2 United States Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
6.3.3 Canada Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
6.3.4 Mexico Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Type (2019-2030)
7.2 Europe Nucleic Acid Multiplex Assay Consumption Value by Application (2019-2030)
7.3 Europe Nucleic Acid Multiplex Assay Market Size by Country
7.3.1 Europe Nucleic Acid Multiplex Assay Consumption Value by Country (2019-2030)
7.3.2 Germany Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
7.3.3 France Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
7.3.5 Russia Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
7.3.6 Italy Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nucleic Acid Multiplex Assay Market Size by Region
8.3.1 Asia-Pacific Nucleic Acid Multiplex Assay Consumption Value by Region (2019-2030)
8.3.2 China Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8.3.3 Japan Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8.3.4 South Korea Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8.3.5 India Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
8.3.7 Australia Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
9 South America
9.1 South America Nucleic Acid Multiplex Assay Consumption Value by Type (2019-2030)
9.2 South America Nucleic Acid Multiplex Assay Consumption Value by Application (2019-2030)
9.3 South America Nucleic Acid Multiplex Assay Market Size by Country
9.3.1 South America Nucleic Acid Multiplex Assay Consumption Value by Country (2019-2030)
9.3.2 Brazil Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
9.3.3 Argentina Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nucleic Acid Multiplex Assay Market Size by Country
10.3.1 Middle East & Africa Nucleic Acid Multiplex Assay Consumption Value by Country (2019-2030)
10.3.2 Turkey Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
10.3.4 UAE Nucleic Acid Multiplex Assay Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Nucleic Acid Multiplex Assay Market Drivers
11.2 Nucleic Acid Multiplex Assay Market Restraints
11.3 Nucleic Acid Multiplex Assay Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Nucleic Acid Multiplex Assay Industry Chain
12.2 Nucleic Acid Multiplex Assay Upstream Analysis
12.3 Nucleic Acid Multiplex Assay Midstream Analysis
12.4 Nucleic Acid Multiplex Assay Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Luminex Corporation (US)
Thermo Fisher Scientific Inc. (US)
Illumina, Inc (US)
Bio-Rad Laboratories, Inc. (US)
Qiagen N.V. (Netherlands)
Abcam plc (UK)
Becton, Dickinson and Company (US)
Merck KGaA (Germany)
Agilent Technologies, Inc. (US)
Meso Scale Diagnostics (US)
Randox Laboratories (UK)
Quanterix (US)
Bio-Techne Corporation (US)
Olink (Sweden)
DiaSorin S.p.A. (Italy)
Seegene (South Korea)
Promega Corporation (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
Shimadzu Biotech (Japan)
Antigenix America, Inc. (US)
Enzo Life Sciences, Inc. (US)
Boster Biological Technology (US)
AYOXXA Biosystems GmbH (Germany)
Cayman Chemical Company (US)
听
听
*If Applicable.
